CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer

Published:2024-04 Issue: Volume:202 Page:107126
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Lv Qi,Zhang Yishu,Gao Wen,Wang Juan,Hu Yaowen,Yang Hongqiong,Xie Ying,Lv Yingshan,Zhang Heyuan,Wu Dapeng,Hu Lihong,Wang Junwei

Funder

Graduate Research and Innovation Projects of Jiangsu Province

Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions

National Natural Science Foundation of China

Jiangsu Province Natural Science Foundation

Publisher

Elsevier BV

Reference57 articles.

1. Global epidemiology and prevention of colorectal cancer;Song;Lancet Gastroenterol. Hepatol.,2022

2. Effect of multimodal prehabilitation vs postoperative rehabilitation on 30-day postoperative complications for frail patients undergoing resection of colorectal cancer: a randomized clinical trial;Carli;JAMA Surg.,2020

3. Comprehensive review of targeted therapy for colorectal cancer;Xie;Signal Transduct. Target Ther.,2020

4. Optimizing immunotherapy for colorectal cancer;Ganesh;Nat. Rev. Gastroenterol. Hepatol.,2022

5. Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer;Bao;Gut,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy;Pharmacological Research;2024-08

2. CSF-1R: A promising therapeutic target for various diseases;Pharmacological Research;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3